Evaluation of the results of the first mass vaccination against pneumococcal disease in the Republic of Kazakhstan

15 Feb 2014

L.T.Yeraliyeva, B.A.Ramazanova, K.K.Mustafina, N.Y. Azimbayeva

S.D. AsfendiyarovKazakh National Medical University

Kazakh State Sanitarium Inspection of Ministry of Health of RK

Pneumococcal disease is a serious medical and social problem in many countries of the world, including Kazakhstan. The only intelligent solution to the problem of pneumococcal carrier, decrease of a large number of various forms of pneumococcal disease and development of antibiotic resistance of pneumococcus – is vaccination. Since 2010, in 2 regions of Kazakhstan  a stepped vaccination against pneumococcal disease has been started and by 2015 these activities will be implemented throughout the country.

Aim of the work – to evaluate the results of 3-year vaccination (2010-2012) against pneumococcal disease in 2 regions of Kazakhstan.

Materials and methods – analysis of statistic data on pneumococcal disease incidence and acute otitis media and infant mortality from pneumonia. (Statistic book “Health of the Republic of Kazakhstan and the activity of health care organizations in 2010, 2011, 2012”).

Results: There is decrease of the incidence of pneumonia per 1000 infants in the East Kazakhstan region by 46%, and accordingly by 49,6% in the Mangystau region. Incidence of acute otitis media also has been decreased in the East Kazakhstan region by 21,3%, and in the Mangystau region in 2,1 times from  19,8% to  9,3%.  Infant mortalityfrompneumonia (per 10000 live-birth infants) in the East Kazakstan region has been decreased by 15,5% and in the Mangystauregion  by 57,1%.

Conclusion  -Implementationofspecificvaccinationagainstpneumococcaldiseasewillreduceinfant and child mortality and disease incidence and may also have impact on the total mortalitydue to producing effect of the community immunity.